Postoperative Effects of TAP Block Versus QLB Type 2 Block
Inguinal Hernia, Postoperative Pain
About this trial
This is an interventional treatment trial for Inguinal Hernia
Eligibility Criteria
Inclusion Criteria:
- Patients who are over 18 years of age
- Patients who are scheduled for elective unilateral open hernia repair with tension free mesh techniques
- Patients who are in ASA's physical status score group 1 or 2
Exclusion Criteria:
- Patients who are younger than 18 years of age
- Patients who have severe stenotic heart diseases
- Patients who have bleeding diathesis
- Patients who have true allergies to local anesthetics
- Patients who have neurologic deficits corresponding to effect site of the anesthetic techniques
Sites / Locations
- Izmir Bozyaka Training and Research Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
TAP
QLB2
CONT
Patients will undergo inguinal hernia repair under subarachnoid block with 0.5% bupivacaine+glucose. Patients will receive transversus abdominis plane block with 20 ml of 0.25% bupivacaine preoperatively, in addition to intravenous acetaminophen 1000mg twice a day for postoperative analgesia. Tramadol HCl 50mg intramuscular will be provided for salvage analgesia postoperatively.
Patients will undergo inguinal hernia repair under subarachnoid block with 0.5% bupivacaine+glucose. Patients will receive quadratus lumborum type 2 block with 20 ml of %0.25 bupivacaine preoperatively, in addition to intravenous acetaminophen 1000mg twice a day for postoperative analgesia. Tramadol HCl 50mg intramuscular will be provided for salvage analgesia postoperatively.
Patients will undergo inguinal hernia repair under subarachnoid block with 0.5% bupivacaine+glucose. Patients will receive intravenous acetaminophen 1000mg twice a day for postoperative analgesia. Tramadol HCl 50mg intramuscular will be provided for salvage analgesia postoperatively.